Literature DB >> 24521609

Severe alkalosis and hypokalemia with stanozolol misuse.

Alexander A N Maini1, Hector Maxwell-Scott1, Daniel J B Marks1.   

Abstract

Stanozolol is a popular androgenic anabolic steroid, used by body builders and athletes for physical performance enhancement. There are few data on its potential adverse effects and no documented cases of it causing severe electrolyte imbalance. Here, we report a patient presenting to a tertiary care emergency department with reduced conscious level, profound hypokalemia, and severe metabolic alkalosis, resulting from stanozolol misuse. This is the first such case reported.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24521609     DOI: 10.1016/j.ajem.2013.09.027

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  4 in total

1.  Vigabatrin-Induced Encephalopathy; Fidaxomicin Hypersensitivity Reactions; Vemurafenib-Induced DRESS; Severe Alkalosis and Hypokalemia With Stanozolol Misuse; Isotretinoin-Associated Lip Abscess; Eltrombopag-Associated Hyperpigmentation.

Authors:  Michael A Mancano
Journal:  Hosp Pharm       Date:  2014-05

2.  Biochemical and oxidative stress markers in the liver and kidneys of rats submitted to different protocols of anabolic steroids.

Authors:  Guilherme Lopes Dornelles; Andressa Bueno; Juliana Sorraila de Oliveira; Aleksandro Schafer da Silva; Raqueli Teresinha França; Cássia Bagolin da Silva; Márcia Silveira Netto Machado; Letícia do Santos Petry; Fátima Husein Abdalla; Cibele Lima Lhamas; Cinthia Melazzo de Andrade
Journal:  Mol Cell Biochem       Date:  2016-11-28       Impact factor: 3.396

3.  Making weight: acute muscle weakness and hypokalaemia exacerbated by thyrotoxicosis factitia in a bodybuilder.

Authors:  Clare E Bonnar; John F Brazil; Julie O Okiro; Louise Giblin; Yvonne Smyth; Paula M O'Shea; Francis M Finucane
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2021-10-01

Review 4.  Treatments for people who use anabolic androgenic steroids: a scoping review.

Authors:  Geoff Bates; Marie-Claire Van Hout; Joseph Tay Wee Teck; Jim McVeigh
Journal:  Harm Reduct J       Date:  2019-12-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.